| Identification | Back Directory | [Name]
IRISQUINONE | [CAS]
56495-82-0 | [Synonyms]
pallasone
IRISQUINONE
Irisquinone A
IRISQUINONE USP/EP/BP
2-(10-heptadecenyl)-6-methoxy-5-cyclohexadiene-(z)-4-dione
2-(10-heptadecenyl)-6-methoxy-5-cyclohexadiene- (z)-4-dione
6-methoxy-2-delta(sup 10')-cis-heptadecenyl-1,4-benzoquinone
2-[(Z)-10-Heptadecenyl]-6-methoxy-2,5-cyclohexadiene-1,4-dione
2-[(Z)-heptadec-10-enyl]-6-methoxycyclohexa-2,5-diene-1,4-dione
2,5-Cyclohexadiene-1,4-dione, 2-(10Z)-10-heptadecen-1-yl-6-methoxy- | [Molecular Formula]
C24H38O3 | [MDL Number]
MFCD01734461 | [MOL File]
56495-82-0.mol | [Molecular Weight]
374.56 |
| Hazard Information | Back Directory | [Uses]
Irisquinone, a natural product, is an anticancer agent. Irisquinone is also a radiation sensitizer for cancer. Irisquinone reduces GSH level and inhibits the repair of DNA singular strand breaks[1][2][3]. | [in vivo]
Irisquinone (12.5 mg/kg, perfused daily) makes the rabbit VX2 lung transplant tumor wall thinner and the necrotic area larger in the irisquinone + radiotherapy group[1].
| Animal Model: | Rabbit bearing VX2 lung transplant tumor[1] | | Dosage: | 12.5 mg/kg | | Administration: | Perfused daily, starting from 3 days before irradiation to the end of irradiation. | | Result: | Displayed no significant difference of tumor growth between the radio therapy and Irisquinone + radiotherapy groups.
Showed thinner tumor wall and the larger necrotic area in the Irisquinone + radiotherapy group. |
| [References]
[1] Xu H, et al. Dynamic observation of the radiosensitive effect of irisquinone on rabbit VX2 lung transplant tumors by using fluorine-18-deoxyglucose positron emission tomography/computed tomography. Nucl Med Commun. 2013 Mar;34(3):220-8. DOI:10.1097/MNM.0b013e32835d3730
[2] Wang H, et al. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT. Nucl Med Commun. 2016 Jul;37(7):705-14. DOI:10.1097/MNM.0000000000000498
[3] Liang, l., et al. The effect of Irisquinone on the glutathione system and MRP expression of cisplatin-resistant human lung adenocarcinoma cell line (A DDP549). Chin J Cancer Res 13, 171–175 (2001). |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
| Company Name: |
Wuhan Topule
|
| Tel: |
+86-02787215551 19945035818 |
| Website: |
www.topule.com/ |
|